Prostate cancer advances help extend a patient's life

September 11, 2018 | Dory Benford

Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.

Continue Reading

Caltech-City of Hope Biomedical Research Initiative marks 10th year of ‘big ideas’

November 12, 2018 | Michael Easterling

Now celebrating its 10th year, the Caltech and City of Hope Biomedical Research Initiative continues to change the future of science and medicine.

Minor diet changes can affect cancer risk, researcher finds

November 9, 2018 | City of Hope

On one hand, City of Hope's Rowan Chlebowski, M.D., Ph.D., is a medical oncologist and breast cancer expert. On the other, he’s a scientist specializing in observational studies who ranks among the most cited researchers in the world.

Groundbreaking new CAR T cell trial opens for patients with breast cancer that has spread to the brain

October 30, 2018 | Letisia Marquez

A new City of Hope chimeric antigen receptor (CAR) T cell trial – the first to focus on HER2-postive breast cancer patients with brain metastases – is now enrolling potential participants. 

Bringing radiation oncology treatment expertise to the Corona community

October 22, 2018 | Maxine Nunes

If radiation is part of your cancer treatment in Corona, California, Paul Mandelin, D.O., is the kind of doctor you hope you can find — a physician who sees you and not just your disease.

Researcher awarded grant to study promising new HIV therapy

October 18, 2018 | Samantha Bonar

The California Institute for Regenerative Medicine has awarded City of Hope’s Xiuli Wang, Ph.D., $3.8 million to develop chimeric antigen receptor (CAR) T cells that can target and kill HIV-infected cells.

Oncologist always finds a way to improve patients’ lives

October 18, 2018 | Maxine Nunes

Whether he finds a cure or simply the most effective way to alleviate pain or other distressing symptoms, Mohammadbagher Ziari, M.D., medical oncologist and hematologist/oncologist at City of Hope in Corona, is often aided by the substantial City of Hope resources he can draw on.

Researchers identify new target for potential type 1 diabetes treatment

October 18, 2018 | Katie Neith

Recently a team of researchers led by City of Hope scientists identified a new potential target to keep the immune system stable and islet beta cells healthy, in an effort to keep type 1 diabetes at bay.

Groundbreaking $2 million study will focus on family caregivers

October 15, 2018 | Maxine Nunes

City of Hope researchers have just received a $2 million grant from the National Cancer Institute to study a crucial but rarely examined aspect of patient care and quality of life — the family caregiver.

A triple-negative breast cancer trial has its first success story

October 12, 2018 | Maxine Nunes

Linda Collins's outlook was bleak, thanks to her triple-negative breast cancer diagnosis, until City of Hope oncologist Yuan Yuan, M.D., Ph.D. helped develop a revolutionary new trial to help her.

City of Hope scientist weighs in on aspirin's role in cancer prevention

October 5, 2018 | Letisia Marquez

The Journal of the American Medical Association Oncology invited City of Hope’s Victoria Seewaldt, M.D., to provide her expert commentary on two studies published today about ovarian and hepatocellular cancer prevention.